ロード中...
Structural basis for drug and substrate specificity exhibited by FIV encoding a chimeric FIV/HIV protease
A chimeric feline immunodeficiency virus (FIV) protease (PR) has been engineered that supports infectivity but confers sensitivity to the human immunodeficiency virus (HIV) PR inhibitors darunavir (DRV) and lopinavir (LPV). The 6s-98S PR has five replacements mimicking homologous residues in HIV PR...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
International Union of Crystallography
2011
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3107052/ https://ncbi.nlm.nih.gov/pubmed/21636894 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1107/S0907444911011681 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|